Bioventix: A Rare Biotech Play with a Low-Risk, High-Return Model
Although it is not clear whether this bond proxy can offer a 20% total return at this level, I see a high chance for it to outperform the benchmark...
194 Views
CK Infra, Ping An Launch $ Bonds; Macro; Rating Changes; New Issues; Talking Heads; Top Gainers &...
US markets extended the rebound rally for a second day amid strong corporate earnings – S&P and Nasdaq gained 0.8% and 0.9% respectively....
180 Views
Airport of Thailand (AOT): 3rd Wave Is a Charm
The sell off AOT soon due to worsening conditions in the third wave of the COVID-19 outbreak.Investors should take advantage of the sell-off in...
250 Views
SGX Asia Currencies and Commodities Insights
By Macro Hive SGX Asia Currencies Insights CNH has traded well against most currencies, and flows remain strong. Therefore, recent USD/CNH...
629 Views
Livzon Pharmaceutical (000513.CH) - A Good Company that You Can't Afford Missing
This article analyzed Livzon's R&D highlights, main products and pipelines, financial position, and made forecast and rating for the Company.
458 Views